Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Attorney Spotlight: Mike Kuffner

February 2, 2017

Mike Kuffner spotlight1. Tell us about your practice.

I represent public and private companies on transactional, corporate governance and securities law matters. I also represent public companies, start-ups and venture capital and private equity firms in connection with corporate finance and capital markets transactions, including registered and unregistered equity and debt offerings. Over the past few years I've also developed a bit of a niche practice representing management teams in the negotiation of their employment and equity packages in connection with buyout transactions.

2. What is an interesting trend happening right now related to your field of practice? 

Deal volume is generally remaining strong despite the uncertainty created by the change in administration. Funds are sitting on a lot of capital, resulting in a competitive marketplace with respect to bidding processes and transaction terms. The general consensus is that the new administration will be more favorable to M&A activity, scaling back regulations and oversight. However, those in the healthcare space are taking calculated risks in deploying capital with respect to attractive transactions while waiting to see what the Trump administration has in store for healthcare reform.

3. Why did you choose to pursue a career in the legal field?

At a basic level, I chose to become a lawyer because I enjoy teamwork and helping people solve their problems. Being a corporate lawyer is very rewarding in that I get to help my clients navigate some of the most important milestones in their careers – whether that be capital raises / changes in ownership, transformative acquisitions or sales of closely held businesses. Being able to provide our clients the comfort that we have the experience to thoughtfully counsel them through those important events is incredibly fulfilling.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.